Article
Functional analysis of altered reduced folate carrier sequence changes identified in osteosarcomas.
Biochimica et biophysica acta - 14 Oct 2004
Flintoff Wayne F, Sadlish Heather, Gorlick Richard, Yang Rui, Williams Frederick M R
Abstract excerpt
Osteosarcomas are common primary malignant bone tumors that do not respond to conventional low-dose treatments of methotrexate (Mtx), suggesting an intrinsic resistance to this drug. Previous work has shown that cDNAs generated from osteosarcoma mRNA from a fraction of patients contain sequence changes in the reduced folate carrier (RFC), the membrane protein transporter for Mtx. In this study, the functionality...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
